[go: up one dir, main page]

PL206810A1 - Sposob wytwarzania nowych pochodnych alkilenodwuaminy - Google Patents

Sposob wytwarzania nowych pochodnych alkilenodwuaminy

Info

Publication number
PL206810A1
PL206810A1 PL20681078A PL20681078A PL206810A1 PL 206810 A1 PL206810 A1 PL 206810A1 PL 20681078 A PL20681078 A PL 20681078A PL 20681078 A PL20681078 A PL 20681078A PL 206810 A1 PL206810 A1 PL 206810A1
Authority
PL
Poland
Prior art keywords
dupamine
alkylene
new derivatives
making new
making
Prior art date
Application number
PL20681078A
Other languages
English (en)
Other versions
PL113762B1 (en
Inventor
Thomas Raabe
Otto Graewinger
Josef Scholtholt
Eckhard Schraven
Original Assignee
Cassella Farbwerke Mainkur Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Farbwerke Mainkur Ag filed Critical Cassella Farbwerke Mainkur Ag
Publication of PL206810A1 publication Critical patent/PL206810A1/pl
Publication of PL113762B1 publication Critical patent/PL113762B1/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PL1978206810A 1977-05-16 1978-05-15 Method of manufacture of novel derivatives of alkylendiamine PL113762B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LU77339A LU77339A1 (pl) 1977-05-16 1977-05-16

Publications (2)

Publication Number Publication Date
PL206810A1 true PL206810A1 (pl) 1979-04-09
PL113762B1 PL113762B1 (en) 1980-12-31

Family

ID=19728575

Family Applications (2)

Application Number Title Priority Date Filing Date
PL1978206810A PL113762B1 (en) 1977-05-16 1978-05-15 Method of manufacture of novel derivatives of alkylendiamine
PL1978215183A PL113674B1 (en) 1977-05-16 1978-05-15 Method of manufacture of novel derivatives of alkylendiamine

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL1978215183A PL113674B1 (en) 1977-05-16 1978-05-15 Method of manufacture of novel derivatives of alkylendiamine

Country Status (30)

Country Link
US (1) US4216314A (pl)
JP (1) JPS53141285A (pl)
AR (1) AR224251A1 (pl)
AT (2) AT359522B (pl)
AU (1) AU3610578A (pl)
BE (1) BE867116A (pl)
BG (2) BG28700A3 (pl)
CA (1) CA1085842A (pl)
CS (1) CS203005B2 (pl)
DD (1) DD135489A5 (pl)
DE (1) DE2819629A1 (pl)
DK (1) DK203078A (pl)
EG (1) EG13302A (pl)
ES (1) ES469895A1 (pl)
FI (1) FI781461A7 (pl)
FR (1) FR2391199A1 (pl)
GB (1) GB1583428A (pl)
GR (1) GR71668B (pl)
IE (1) IE46895B1 (pl)
IT (1) IT1158712B (pl)
LU (1) LU77339A1 (pl)
NL (1) NL7804966A (pl)
NO (1) NO781635L (pl)
NZ (1) NZ187272A (pl)
PL (2) PL113762B1 (pl)
PT (1) PT68044B (pl)
RO (1) RO75870A (pl)
SE (1) SE7805260L (pl)
SU (2) SU793389A3 (pl)
ZA (1) ZA782758B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3023369A1 (de) * 1980-06-23 1982-01-14 Boehringer Mannheim Gmbh, 6800 Mannheim Aryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3048487A1 (de) * 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
DE3131146A1 (de) * 1981-08-06 1983-02-24 Boehringer Mannheim Gmbh, 6800 Mannheim Neue heteroaryloxypropanolamine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
JPS59225170A (ja) * 1983-06-07 1984-12-18 Mitsui Toatsu Chem Inc アミノプロパノ−ル誘導体、その製造法、および該化合物を含有する心臓選択性β−アドレナリン作用遮断剤
JPH0637479B2 (ja) * 1987-12-28 1994-05-18 三井東圧化学株式会社 新規ピリミジン誘導体、その製造法およびそれを含有する抗不整脈剤
US5008267A (en) * 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
JP2815218B2 (ja) * 1990-04-13 1998-10-27 三井化学株式会社 ピリミジンジオン誘導体、およびそれを含有する抗不整脈剤
US5308848A (en) * 1989-10-24 1994-05-03 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione derivatives and antiarrythmic agents containing the same
JPH03173885A (ja) * 1989-12-01 1991-07-29 Mitsui Toatsu Chem Inc ピリミジンジオン誘導体化合物、該化合物の製造法および該化合物を含む抗不整脈剤
JPH0413669A (ja) * 1990-04-27 1992-01-17 Mitsui Toatsu Chem Inc 新規ピリミジンジオン誘導体及び該化合物を含有する抗不整脈剤
DE4035599A1 (de) * 1990-11-06 1992-05-07 Dresden Arzneimittel Neue 5-(phenoxyalkanoylamino)-uracile, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
CA2446550C (en) * 2001-05-11 2012-03-06 Endo Pharmaceuticals, Inc. Abuse-resistant controlled-release opioid dosage form
KR100784341B1 (ko) 2002-04-05 2007-12-13 유로-셀띠끄 소시에떼 아노님 활성 화합물의 지속적, 불변적 및 독립적 방출용 매트릭스
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
SMT201900023T1 (it) 2009-03-10 2019-02-28 Euro Celtique Sa Composizioni farmaceutiche a rilascio immediato comprendenti ossicodone e naloxone
WO2015011189A1 (en) 2013-07-23 2015-01-29 Euro-Celtique S.A. A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787103A (fr) * 1971-08-04 1973-02-02 Pfizer Nouveaux derives de propanolamine et composition pharmaceutiqueles contenant
US4020071A (en) * 1973-12-20 1977-04-26 Cassella Farbwerke Mainkur Aktiengesellschaft Derivatives of 1-phenoxy-3-amino-propan-2-ol

Also Published As

Publication number Publication date
ZA782758B (en) 1979-05-30
DD135489A5 (de) 1979-05-09
FR2391199A1 (fr) 1978-12-15
NO781635L (no) 1978-11-17
SU793389A3 (ru) 1980-12-30
SU841587A3 (ru) 1981-06-23
AT359523B (de) 1980-11-10
LU77339A1 (pl) 1979-01-19
IT7823416A0 (it) 1978-05-15
BG28700A3 (bg) 1980-06-16
GB1583428A (en) 1981-01-28
DK203078A (da) 1978-11-17
AR224251A1 (es) 1981-11-13
ATA342978A (de) 1980-04-15
SE7805260L (sv) 1978-11-17
NL7804966A (nl) 1978-11-20
RO75870A (ro) 1982-12-06
ES469895A1 (es) 1979-09-16
FR2391199B1 (pl) 1981-07-24
PL113674B1 (en) 1980-12-31
AT359522B (de) 1980-11-10
BE867116A (fr) 1978-11-16
GR71668B (pl) 1983-06-20
CS203005B2 (en) 1981-02-27
IE780971L (en) 1978-11-16
DE2819629A1 (de) 1978-11-30
BG28699A3 (bg) 1980-06-16
ATA343078A (de) 1980-04-15
IE46895B1 (en) 1983-10-19
PL113762B1 (en) 1980-12-31
PT68044B (de) 1979-10-24
NZ187272A (en) 1979-12-11
IT1158712B (it) 1987-02-25
FI781461A7 (fi) 1978-11-17
AU3610578A (en) 1979-11-22
CA1085842A (en) 1980-09-16
PT68044A (de) 1978-06-01
US4216314A (en) 1980-08-05
JPS53141285A (en) 1978-12-08
EG13302A (en) 1983-09-30

Similar Documents

Publication Publication Date Title
PL205287A1 (pl) Sposob wytwarzania nowych 4-acyloaminofenylo-etanoloamin
PL202305A1 (pl) Sposob wytwarzania furanokumaryny
PL206810A1 (pl) Sposob wytwarzania nowych pochodnych alkilenodwuaminy
PL207835A1 (pl) Sposob etylowania monoalkilobenzenu
PL207887A1 (pl) Sposob wytwarzania parabenzochinonu
PL210045A1 (pl) Sposob wytwarzania nowych pochodnych czteropeptydow
PL206450A1 (pl) Sposob wytwarzania pochodnych mocznika
PL204134A1 (pl) Sposob wytwarzania nowych pochodnych aminoalkoksyfenylowych
PL206456A1 (pl) Sposob wytwarzania pochodnych pirydazynonu-3
PL211409A1 (pl) Sposob wytwarzania nowych podstawionych pirolidyn
PL208434A1 (pl) Sposob wytwarzania nowych pochodnych benzopiranu
PL206833A1 (pl) Sposob wytwarzania nowych pochodnych 6-aminopenamu
PL211328A1 (pl) Sposob wytwarzania nowych pochodnych fenoksyalkanoloaminy
PL204428A1 (pl) Sposob wytwarzania nowych pochodnych erytomycyny
PL209049A1 (pl) Sposob wytwarzania nowych pochodnych 1-fenyloetanoloaminy
PL209122A1 (pl) Sposob wytwarzania nowych pochodnych 3-amino-17 alfa-aza-d-homo-5 alfa-androstanu
PL210932A1 (pl) Sposob wytwarzania tiolokarbaminianow
PL209329A1 (pl) Sposob wytwarzania 2-chlorosulfinyloazetydynonow-4
PL211668A1 (pl) Sposob wytwarzania nowych 3-dwu-n-propyloacetoksybenzodiazepinonow-2
PL204964A1 (pl) Sposob wytwarzania akantomycyny
PL205590A1 (pl) Sposob wytwarzania 2-hydroksybenzotiazoli
PL198559A1 (pl) Sposob wytwarzania dwu-n-propylo-acetonitrylu
PL208406A1 (pl) Sposob wytwarzania pochodnych furokumaryny
PL204882A1 (pl) Sposob wytwarzania nowych triazolo-tieno-dwuazepinonow-1
PL196842A1 (pl) Sposob wytwarzania nowych zasadowych barwnikow metinowych